Ann Mongan

842 total citations
17 papers, 627 citations indexed

About

Ann Mongan is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Ann Mongan has authored 17 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Genetics and 4 papers in Surgery. Recurrent topics in Ann Mongan's work include Chronic Lymphocytic Leukemia Research (5 papers), Esophageal Cancer Research and Treatment (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Ann Mongan is often cited by papers focused on Chronic Lymphocytic Leukemia Research (5 papers), Esophageal Cancer Research and Treatment (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Ann Mongan collaborates with scholars based in United States, Ireland and Australia. Ann Mongan's co-authors include M. Eggers, John V. Reynolds, Suzanne L. Doyle, Joanne Lysaght, Graham P. Pidgeon, Claire L. Donohoe, Julia Howard, Fiona E. Lithander, James P. Dean and Jan A. Burger and has published in prestigious journals such as Blood, Cancer Research and Gut.

In The Last Decade

Ann Mongan

17 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann Mongan United States 9 274 146 131 120 108 17 627
Nobuhisa Yoshikawa Japan 18 266 1.0× 253 1.7× 147 1.1× 41 0.3× 35 0.3× 91 980
Ryo Tanaka Japan 14 210 0.8× 411 2.8× 105 0.8× 37 0.3× 35 0.3× 51 956
T Rott Slovenia 13 176 0.6× 50 0.3× 65 0.5× 61 0.5× 25 0.2× 35 576
Jason H. Kurzer United States 13 233 0.9× 182 1.2× 19 0.1× 26 0.2× 37 0.3× 28 633
Stefania Oliva Italy 12 315 1.1× 269 1.8× 40 0.3× 14 0.1× 32 0.3× 23 578
Anna Maria Granato Italy 17 246 0.9× 365 2.5× 36 0.3× 23 0.2× 27 0.3× 38 657
E. Röttinger Germany 11 208 0.8× 180 1.2× 183 1.4× 27 0.2× 120 1.1× 30 554
Yongzhong Li United States 12 269 1.0× 90 0.6× 112 0.9× 9 0.1× 26 0.2× 20 564
Sim Leng Tien Singapore 12 112 0.4× 78 0.5× 42 0.3× 13 0.1× 82 0.8× 41 448
Wen Gao China 13 187 0.7× 225 1.5× 59 0.5× 44 0.4× 24 0.2× 51 717

Countries citing papers authored by Ann Mongan

Since Specialization
Citations

This map shows the geographic impact of Ann Mongan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann Mongan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann Mongan more than expected).

Fields of papers citing papers by Ann Mongan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann Mongan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann Mongan. The network helps show where Ann Mongan may publish in the future.

Co-authorship network of co-authors of Ann Mongan

This figure shows the co-authorship network connecting the top 25 collaborators of Ann Mongan. A scholar is included among the top collaborators of Ann Mongan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann Mongan. Ann Mongan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Blum, Lisa K., Jan A. Burger, Thomas J. Kipps, et al.. (2021). Impact of long-term ibrutinib treatment on circulating immune cells in previously untreated chronic lymphocytic leukemia. Leukemia Research. 102. 106520–106520. 35 indexed citations
3.
Blum, Lisa K., Thomas J. Kipps, Jan A. Burger, et al.. (2020). Ibrutinib restores immune cell numbers and function in first-line and relapsed/refractory chronic lymphocytic leukemia. Leukemia Research. 97. 106432–106432. 57 indexed citations
4.
Gururaja, Tarikere, et al.. (2019). Relative Selectivity of Covalent Inhibitors Requires Assessment of Inactivation Kinetics and Cellular Occupancy: A Case Study of Ibrutinib and Acalabrutinib. Journal of Pharmacology and Experimental Therapeutics. 372(3). 331–338. 25 indexed citations
5.
Mongan, Ann, Niamh Lynam‐Lennon, Suzanne L. Doyle, et al.. (2019). Visceral Adipose Tissue Modulates Radiosensitivity in Oesophageal Adenocarcinoma. International Journal of Medical Sciences. 16(4). 519–528. 12 indexed citations
7.
O’Brien, Susan, Stephen P. Mulligan, John C. Byrd, et al.. (2018). Ibrutinib Treatment Improves T-Cell Proliferative Ability and Effector Function in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients. Blood. 132(Supplement 1). 3114–3114. 1 indexed citations
8.
Doyle, Suzanne L., Ann Mongan, Claire L. Donohoe, et al.. (2017). Impact of visceral obesity and metabolic syndrome on the postoperative immune, inflammatory, and endocrine response following surgery for esophageal adenocarcinoma. Diseases of the Esophagus. 30(6). 1–11. 21 indexed citations
9.
Lynam‐Lennon, Niamh, B. Bibby, Ann Mongan, et al.. (2016). Low MiR-187 Expression Promotes Resistance to Chemoradiation Therapy In Vitro and Correlates with Treatment Failure in Patients with Esophageal Adenocarcinoma. Molecular Medicine. 22(1). 388–397. 27 indexed citations
10.
Conroy, Melissa J., Karen Galvin, María Kavanagh, et al.. (2016). CCR1 antagonism attenuates T cell trafficking to omentum and liver in obesity‐associated cancer. Immunology and Cell Biology. 94(6). 531–537. 24 indexed citations
11.
Gu, Jian, Dumitru Brinza, Ann Mongan, et al.. (2016). Abstract 3622: Complete workflow for detection of low frequency somatic mutations from cell-free DNA using Ion Torrent™ platforms. Cancer Research. 76(14_Supplement). 3622–3622. 1 indexed citations
12.
Mongan, Ann, Niamh Lynam‐Lennon, Stephen G. Maher, et al.. (2015). Visceral obesity stimulates anaphase bridge formation and spindle assembly checkpoint dysregulation in radioresistant oesophageal adenocarcinoma. Clinical & Translational Oncology. 18(6). 632–640. 5 indexed citations
13.
Mongan, Ann, Sinéad King, Naoimh J. O’Farrell, et al.. (2014). Outcomes in gastric and junctional cancer using neoadjuvant and adjuvant chemotherapy (epirubicin, oxaliplatin, and capecitabine) and radical surgery. Irish Journal of Medical Science (1971 -). 184(2). 417–423. 8 indexed citations
14.
Doyle, Suzanne L., Claire L. Donohoe, Ann Mongan, et al.. (2013). Establishing computed tomography–defined visceral fat area thresholds for use in obesity-related cancer research. Nutrition Research. 33(3). 171–179. 148 indexed citations
15.
Mongan, Ann, Niamh Lynam‐Lennon, Stephen G. Maher, et al.. (2012). OC-123 Obesity drives radioresistance and enhances genomic instability in oesophageal adenocarcinoma. Gut. 61(Suppl 2). A53.2–A53. 2 indexed citations
16.
Mongan, Ann, et al.. (2008). Assessment of Repeated Microarray Experiments using Mixed Tissue RNA Reference Samples. BioTechniques. 45(3). 283–292. 5 indexed citations
17.
Mongan, Ann, et al.. (1999). High-Throughput Microarray-Based Enzyme-Linked Immunosorbent Assay (ELISA). BioTechniques. 27(4). 778–788. 251 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026